Outcome of Noncatheter-Related Thrombosis in Children: Influence of Underlying or Coexisting Factors
- 1 March 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 23 (3) , 159-164
- https://doi.org/10.1097/00043426-200103000-00007
Abstract
To determine the hereditary and nonhereditary risk factors contributing to the development of noncatheter-related thrombosis in children. Ninety-five children with noncatheter-related thrombosis from a single center were analyzed for clinical manifestations and outcome during a period of 3.5 years. Patients with thrombosis were evaluated for congenital and acquired risk factors, and patients were screened for factor V Leiden, prothrombin 20210A mutations, protein C, protein S, antithrombin III deficiencies, and antiphospholipid antibodies. Twelve patients (12.5%) died of thrombosis that was associated with a nonmalignant underlying disorder, and 19 patients (20%) had significant complications, including amputation of extremities, epilepsy, hemiplegia, portal hypertension, recurrence of deep vein thrombosis, and postphlebitic syndrome. Two common mutations (factor V Leiden and prothrombin 20210A) were found in 32.5% of the patients with thrombosis. The most frequent underlying disorder was infection (68%). Ninety-three patients (98%) had one or more risk factors. The coexistence of an underlying disorder and the presence of predisposing factors such as infection and the factor V Leiden mutation may cause high rates of death and complications in children with noncatheter-related thrombosis. The results of this study indicate that the underlying disorder and the site of thrombosis determine the rates of death and complications in children with thrombosis.Keywords
This publication has 22 references indexed in Scilit:
- Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood ThrombophiliaArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Congenital thrombophilia and thrombosis: a study in a single centreArchives of Disease in Childhood, 1999
- CLINICAL MANIFESTATIONS IN THROMBOTIC CHILDREN WITH FACTOR V LEIDEN MUTATIONPediatric Hematology and Oncology, 1999
- VENOUS THROMBOEMBOLIC EVENTS IN PEDIATRIC PATIENTSHematology/Oncology Clinics of North America, 1998
- Ischaemic stroke in infancy and childhoodBlood Coagulation & Fibrinolysis, 1996
- Resistance to activated protein C (APCR) in children with venous or arterial thromboembolismBritish Journal of Haematology, 1996
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide a in systemic meningococcal diseaseThrombosis Research, 1989
- Purpura Fulminans in Meningococcemia: Association with Acquired Deficiencies of Proteins C and SNew England Journal of Medicine, 1987
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.Journal of Clinical Investigation, 1987